FTY720, which is clinically approved for the treatment of MS, works by reducing the level of circulating T cells by promoting their homing to lymph nodes.8,9 Herein, we investigated the effects of FTY720 on tau phosphorylation and brain atrophy in a mouse model of tauopathy. This evidence concerns the gene MAPT and myeloid sarcoma.